Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
More Reading from MarketBeat 3 Blue-Chip Stocks Built for a Rotating MarketSubmitted by Chris Markoch. Published: 3/8/2026. 
Key Points - Sector rotation in 2026 is favoring defensive, value-oriented areas such as utilities, healthcare, and consumer staples over mega-cap technology.
- Duke Energy and Gilead Sciences combine defensive characteristics with identifiable growth catalysts and reliable dividends.
- Hershey has rallied sharply with consumer staples, but its valuation now looks stretched relative to its earnings profile.
- Special Report: Have $500? Invest in Elon's AI Masterplan
Sector rotation refers to investors moving money out of market sectors that look overbought and into ones that seem undervalued. In 2026, that has meant rotating away from mega-cap technology names and into value stocks, particularly defensive sectors like energy and consumer staples. The key word is "overvalued." Big tech has run hot for more than two years, much of it driven by the emergence of artificial intelligence (AI). Despite concerns about a repeat of the dot-com bubble, investors largely ignored the lofty valuations of many of these names. The Fed is counting on the fact that ordinary Americans won't read a 93-page document until it's too late. I've read it and that's why I'm begging you to act while you still can. Get the 4 "Fed-proof" steps right now. Investors who believed "this time is different" are finding that valuation doesn't matter until it does. As the economy begins to heat up, buyers are looking for value elsewhere—often in blue-chip defensive names like the stocks listed here. Utilities Provide Stability in a Rotating Market Duke Energy (NYSE: DUK) is a logical beneficiary of sector rotation. A major utility in the Southeast and Midwest, utilities are among the most defensive sectors—typically viewed as value and income plays. Duke offers an attractive, relatively secure dividend that yields about 3.2% and has increased its payout for 20 consecutive years. The changing U.S. energy landscape also creates room for future growth for DUK. The company follows an "all of the above" approach to generation, including nuclear, hydroelectric and natural gas. Natural gas has helped drive the stock's strong bounce in 2026, but Duke's stable residential utility revenue and projected growth in areas such as data centers are additional reasons investors are rotating into DUK. DUK is up nearly 12% in 2026, putting it within roughly 5% of the consensus price target of $136.87, which would push the stock above its 52-week high. Trading around 20.5x earnings, the shares sit at a slight premium to their historical average. Since Duke reported earnings in February, analysts have been raising price targets amid expectations of strong year-over-year revenue growth in the second half of the year—an outlook that could prompt a bullish re-rating. Biotech Strength Gives Gilead Defensive Growth Some analysts expect biotech stocks to benefit from the current sector rotation. Gilead Sciences (NASDAQ: GILD) offers defensive growth within healthcare, a sector that has largely underperformed the broader market. Gilead is a leading provider of HIV therapies, with key treatments protected by patents into the 2030s. Investors are also encouraged by a pipeline of more than 50 candidates. Beyond HIV, Gilead expects to launch anito-cel, a CAR-T therapy for multiple myeloma in 2026, and the company may see a label expansion for its breast cancer drug Trodelvy. GILD is up nearly 18% in 2026, a move that pushed the stock to a 52-week high before it pulled back slightly—likely profit-taking after an outsized run—creating a potential buy-the-dip opportunity. Analysts' consensus price target of $156.72 implies a gain of more than 8%, and since February's earnings report many analysts have raised targets, with the highest estimates near $170. Gilead also pays a dependable dividend, yielding about 2.28%, and the company has increased its payout for 10 consecutive years. Consumer Staples Rally Lifts Hershey Stock The Hershey Company (NYSE: HSY) is among the biggest beneficiaries of the rotation into consumer staples in 2026. HSY is up nearly 25% this year and has broken out of the bearish trend that began in 2023. Higher cocoa prices since 2023 weighed on results through 2025 and will continue to pressure earnings in 2026. Still, the market looks forward, and analysts are forecasting strong earnings and revenue growth for the year. HSY is trading above its consensus price target of $222.21, but analysts have been lifting targets since the company's February report. The most bullish call—Goldman Sachs—has a $267 target. In that report, Hershey raised its dividend by 5.9%, marking 15 consecutive years of increases. The stock yields roughly 2.5% and carries an annual payout per share of $5.81. After the recent rally, HSY is trading at over 50x earnings, which likely contributed to heavy institutional selling last quarter—but it may also give investors a chance to pick up a second bite of this sweet stock.
| 
